Hepatoerythropoietic Porphyria.
Rudnick S, Phillips J, Bonkovsky H; Porphyrias Consortium of the Rare Diseases Clinical Research Network.
Rudnick S, et al.
2013 Oct 31 [updated 2022 Dec 22]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
2013 Oct 31 [updated 2022 Dec 22]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.
PMID: 24175354
Free Books & Documents.
Review.
CLINICAL CHARACTERISTICS: Hepatoerythropoietic porphyria (HEP) is characterized by blistering skin lesions, hypertrichosis, and scarring over the affected skin areas. ...Phlebotomy and chloroquine, which are usually effective in treating the allelic disorder familia …
CLINICAL CHARACTERISTICS: Hepatoerythropoietic porphyria (HEP) is characterized by blistering skin lesions, hypertrichosis, an …